The Multiple Sclerosis Market is projected to reach USD 43.40 billion by 2032.
From GlobeNewswire: 2025-02-19 09:00:00
The Multiple Sclerosis Market is projected to grow from USD 23.64 billion in 2023 to USD 43.40 billion by 2032, with a CAGR of 7.0% from 2024-2032. The growth is driven by advancements in MS therapies, increased awareness of the disease, and rising demand for immunosuppressive and immunostimulant drugs.
Key players in the market include Teva Pharmaceutical Industries Ltd., Pfizer Inc., Biogen, Bayer AG, Sanofi, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Takeda Pharmaceutical Company Limited, and Horizon Therapeutics plc.
In 2023, the market was dominated by immunosuppressants, while injectables led in route of administration and hospital pharmacies in distribution channels. Oral administration and retail pharmacies are expected to show significant growth in the coming years.
North America led the market in 2023, with the Asia-Pacific region expected to witness the fastest growth due to increased healthcare spending and rising MS awareness. Recent developments include new research approaches, approved formulations, and the launch of safer and more effective MS therapies. The latest report on Multiple Sclerosis Market Analysis & Outlook 2024-2032 provides insights on global trends. It includes statistics on incidence, prevalence, prescription trends, and healthcare spending by region in 2023. The report also covers MS research, patient demographics, treatment adherence, competitive landscape, drug classes, and distribution channels.
For complete details of the report, visit SNS Insider’s website. SNS Insider is a top market research and consulting agency offering accurate and current market data to help clients make informed decisions. Utilizing various techniques like surveys and focus groups, they provide valuable consumer insights and opinions for navigating changing market conditions.
Read more at GlobeNewswire: Multiple Sclerosis Market Size to Hit USD 43.40 Billion by